Global Liquid Biopsy Supply, Demand and Key Producers, 2026-2032
The global Liquid Biopsy market size is expected to reach $ 15888 million by 2032, rising at a market growth of 18.8% CAGR during the forecast period (2026-2032).
Liquid biopsy is a molecular diagnostic technology that detects tumor-related biomarkers in body fluids such as blood, urine, or cerebrospinal fluid to enable disease screening, diagnosis, treatment monitoring, and recurrence surveillance. Compared with conventional tissue biopsy, liquid biopsy offers significant advantages including minimal invasiveness, repeatable sampling, and the ability to perform real-time dynamic monitoring. The technology primarily analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and tumor-derived RNA using advanced analytical platforms such as next-generation sequencing and digital PCR. Liquid biopsy provides a more comprehensive view of tumor molecular characteristics and heterogeneity, making it an important tool in precision medicine. With continuous advancements in genomic technologies, bioinformatics, and the growing demand for early cancer detection, liquid biopsy is increasingly becoming a key component of modern oncology diagnostics and translational research.The average gross profit margin of this product is 65%.
The continuous evolution of precision medicine is transforming clinical practice from empirical treatment toward molecular classification and personalized therapy, creating significant opportunities for liquid biopsy technologies. Increasing demand for sensitive molecular diagnostics in cancer screening, targeted therapy, and immunotherapy has positioned liquid biopsy as a critical bridge between diagnostics and treatment decision-making. Meanwhile, the declining cost of sequencing technologies and improvements in bioinformatics capabilities are enhancing the accessibility and scalability of liquid biopsy applications. Global pharmaceutical companies and research institutions are also increasing investments in early cancer detection and companion diagnostics, further accelerating technological innovation and commercialization in this field.
Despite its strong potential, liquid biopsy still faces several technical and regulatory challenges in clinical adoption. The extremely low concentration of tumor-derived molecules in body fluids requires highly sensitive and specific detection technologies, placing stringent demands on experimental workflows, analytical platforms, and data interpretation. In addition, the lack of standardized methodologies across different testing platforms may affect result consistency and clinical interpretation. Regulatory requirements for molecular diagnostic products are also becoming more rigorous, and the need for extensive clinical validation can lengthen the approval and commercialization process, potentially slowing market penetration.
Downstream demand for liquid biopsy is gradually expanding from late-stage cancer monitoring to broader clinical applications. Early cancer screening, treatment response evaluation, minimal residual disease detection, and recurrence monitoring are becoming increasingly important application areas. As precision oncology strategies continue to evolve, clinicians are relying more on dynamic molecular testing to guide treatment decisions, strengthening the role of liquid biopsy in clinical workflows. In addition, biopharmaceutical companies are increasingly adopting liquid biopsy technologies as companion diagnostic tools and research instruments in drug development, making them valuable in clinical trials and real-world evidence studies.
The upstream segment of the liquid biopsy industry mainly includes nucleic acid extraction reagents, sample preservation and stabilization reagents, sequencing reagents, and high-sensitivity molecular detection consumables. These materials directly influence detection sensitivity, stability, and experimental reproducibility, making them fundamental to overall test performance. As molecular diagnostics technologies continue to evolve, reagent suppliers are developing more efficient nucleic acid enrichment solutions and high-stability reagents to meet the demands of ultra-low concentration biomarker detection. Continuous improvements in automated sample processing systems and high-performance sequencing platforms are also driving technological advancement and scalability across the entire industry chain.
This report studies the global Liquid Biopsy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liquid Biopsy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liquid Biopsy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liquid Biopsy total market, 2021-2032, (USD Million)
Global Liquid Biopsy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Liquid Biopsy total market, key domestic companies, and share, (USD Million)
Global Liquid Biopsy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Liquid Biopsy total market by Type, CAGR, 2021-2032, (USD Million)
Global Liquid Biopsy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Liquid Biopsy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, Biocept, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Liquid Biopsy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Liquid Biopsy Market, By Region:
1. How big is the global Liquid Biopsy market?
2. What is the demand of the global Liquid Biopsy market?
3. What is the year over year growth of the global Liquid Biopsy market?
4. What is the total value of the global Liquid Biopsy market?
5. Who are the Major Players in the global Liquid Biopsy market?
6. What are the growth factors driving the market demand?
Liquid biopsy is a molecular diagnostic technology that detects tumor-related biomarkers in body fluids such as blood, urine, or cerebrospinal fluid to enable disease screening, diagnosis, treatment monitoring, and recurrence surveillance. Compared with conventional tissue biopsy, liquid biopsy offers significant advantages including minimal invasiveness, repeatable sampling, and the ability to perform real-time dynamic monitoring. The technology primarily analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and tumor-derived RNA using advanced analytical platforms such as next-generation sequencing and digital PCR. Liquid biopsy provides a more comprehensive view of tumor molecular characteristics and heterogeneity, making it an important tool in precision medicine. With continuous advancements in genomic technologies, bioinformatics, and the growing demand for early cancer detection, liquid biopsy is increasingly becoming a key component of modern oncology diagnostics and translational research.The average gross profit margin of this product is 65%.
The continuous evolution of precision medicine is transforming clinical practice from empirical treatment toward molecular classification and personalized therapy, creating significant opportunities for liquid biopsy technologies. Increasing demand for sensitive molecular diagnostics in cancer screening, targeted therapy, and immunotherapy has positioned liquid biopsy as a critical bridge between diagnostics and treatment decision-making. Meanwhile, the declining cost of sequencing technologies and improvements in bioinformatics capabilities are enhancing the accessibility and scalability of liquid biopsy applications. Global pharmaceutical companies and research institutions are also increasing investments in early cancer detection and companion diagnostics, further accelerating technological innovation and commercialization in this field.
Despite its strong potential, liquid biopsy still faces several technical and regulatory challenges in clinical adoption. The extremely low concentration of tumor-derived molecules in body fluids requires highly sensitive and specific detection technologies, placing stringent demands on experimental workflows, analytical platforms, and data interpretation. In addition, the lack of standardized methodologies across different testing platforms may affect result consistency and clinical interpretation. Regulatory requirements for molecular diagnostic products are also becoming more rigorous, and the need for extensive clinical validation can lengthen the approval and commercialization process, potentially slowing market penetration.
Downstream demand for liquid biopsy is gradually expanding from late-stage cancer monitoring to broader clinical applications. Early cancer screening, treatment response evaluation, minimal residual disease detection, and recurrence monitoring are becoming increasingly important application areas. As precision oncology strategies continue to evolve, clinicians are relying more on dynamic molecular testing to guide treatment decisions, strengthening the role of liquid biopsy in clinical workflows. In addition, biopharmaceutical companies are increasingly adopting liquid biopsy technologies as companion diagnostic tools and research instruments in drug development, making them valuable in clinical trials and real-world evidence studies.
The upstream segment of the liquid biopsy industry mainly includes nucleic acid extraction reagents, sample preservation and stabilization reagents, sequencing reagents, and high-sensitivity molecular detection consumables. These materials directly influence detection sensitivity, stability, and experimental reproducibility, making them fundamental to overall test performance. As molecular diagnostics technologies continue to evolve, reagent suppliers are developing more efficient nucleic acid enrichment solutions and high-stability reagents to meet the demands of ultra-low concentration biomarker detection. Continuous improvements in automated sample processing systems and high-performance sequencing platforms are also driving technological advancement and scalability across the entire industry chain.
This report studies the global Liquid Biopsy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liquid Biopsy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liquid Biopsy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liquid Biopsy total market, 2021-2032, (USD Million)
Global Liquid Biopsy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Liquid Biopsy total market, key domestic companies, and share, (USD Million)
Global Liquid Biopsy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Liquid Biopsy total market by Type, CAGR, 2021-2032, (USD Million)
Global Liquid Biopsy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Liquid Biopsy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, Biocept, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Liquid Biopsy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Liquid Biopsy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Test Suite
- Equipment
- Service
- NGS Sequencing
- Digital PCR
- Real-time PCR
- Other
- Blood Sample
- Urine Sample
- Other
- Hospitals Labs
- Reference Labs
- Other
- RainDanceTechnologies
- Biocartis
- Qiagen
- Guardant Health
- MDxHealth
- Pathway Genomics
- Biocept
- NeoGenomics Laboraories
- Sysmex Inostics
- Cynvenio
- Silicon Biosystems
- Adaptive Biotechnologies
- 4D Lifetec
- Roche
- Illumina
- Exact Sciences
- Natera
- Foundation Medicine
- Thermo Fisher Scientific
- Bio-Rad Laboratories
1. How big is the global Liquid Biopsy market?
2. What is the demand of the global Liquid Biopsy market?
3. What is the year over year growth of the global Liquid Biopsy market?
4. What is the total value of the global Liquid Biopsy market?
5. Who are the Major Players in the global Liquid Biopsy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Liquid Biopsy Introduction
1.2 World Liquid Biopsy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Liquid Biopsy Total Market by Region (by Headquarter Location)
1.3.1 World Liquid Biopsy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Liquid Biopsy Revenue (2021-2032)
1.3.3 China Based Company Liquid Biopsy Revenue (2021-2032)
1.3.4 Europe Based Company Liquid Biopsy Revenue (2021-2032)
1.3.5 Japan Based Company Liquid Biopsy Revenue (2021-2032)
1.3.6 South Korea Based Company Liquid Biopsy Revenue (2021-2032)
1.3.7 ASEAN Based Company Liquid Biopsy Revenue (2021-2032)
1.3.8 India Based Company Liquid Biopsy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liquid Biopsy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Liquid Biopsy Consumption Value (2021-2032)
2.2 World Liquid Biopsy Consumption Value by Region
2.2.1 World Liquid Biopsy Consumption Value by Region (2021-2026)
2.2.2 World Liquid Biopsy Consumption Value Forecast by Region (2027-2032)
2.3 United States Liquid Biopsy Consumption Value (2021-2032)
2.4 China Liquid Biopsy Consumption Value (2021-2032)
2.5 Europe Liquid Biopsy Consumption Value (2021-2032)
2.6 Japan Liquid Biopsy Consumption Value (2021-2032)
2.7 South Korea Liquid Biopsy Consumption Value (2021-2032)
2.8 ASEAN Liquid Biopsy Consumption Value (2021-2032)
2.9 India Liquid Biopsy Consumption Value (2021-2032)
3 WORLD LIQUID BIOPSY COMPANIES COMPETITIVE ANALYSIS
3.1 World Liquid Biopsy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Liquid Biopsy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Liquid Biopsy in 2025
3.2.3 Global Concentration Ratios (CR8) for Liquid Biopsy in 2025
3.3 Liquid Biopsy Company Evaluation Quadrant
3.4 Liquid Biopsy Market: Overall Company Footprint Analysis
3.4.1 Liquid Biopsy Market: Region Footprint
3.4.2 Liquid Biopsy Market: Company Product Type Footprint
3.4.3 Liquid Biopsy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Liquid Biopsy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Liquid Biopsy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Liquid Biopsy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Liquid Biopsy Consumption Value Comparison
4.2.1 United States VS China: Liquid Biopsy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Liquid Biopsy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Liquid Biopsy Companies and Market Share, 2021-2026
4.3.1 United States Based Liquid Biopsy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Liquid Biopsy Revenue, (2021-2026)
4.4 China Based Companies Liquid Biopsy Revenue and Market Share, 2021-2026
4.4.1 China Based Liquid Biopsy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Liquid Biopsy Revenue, (2021-2026)
4.5 Rest of World Based Liquid Biopsy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Liquid Biopsy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Liquid Biopsy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Liquid Biopsy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Test Suite
5.2.2 Equipment
5.2.3 Service
5.3 Market Segment by Type
5.3.1 World Liquid Biopsy Market Size by Type (2021-2026)
5.3.2 World Liquid Biopsy Market Size by Type (2027-2032)
5.3.3 World Liquid Biopsy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY PLATFORM
6.1 World Liquid Biopsy Market Size Overview by Technology Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Platform
6.2.1 NGS Sequencing
6.2.2 Digital PCR
6.2.3 Real-time PCR
6.2.4 Other
6.3 Market Segment by Technology Platform
6.3.1 World Liquid Biopsy Market Size by Technology Platform (2021-2026)
6.3.2 World Liquid Biopsy Market Size by Technology Platform (2027-2032)
6.3.3 World Liquid Biopsy Market Size Market Share by Technology Platform (2027-2032)
7 MARKET ANALYSIS BY SAMPLE
7.1 World Liquid Biopsy Market Size Overview by Sample: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sample
7.2.1 Blood Sample
7.2.2 Urine Sample
7.2.3 Other
7.3 Market Segment by Sample
7.3.1 World Liquid Biopsy Market Size by Sample (2021-2026)
7.3.2 World Liquid Biopsy Market Size by Sample (2027-2032)
7.3.3 World Liquid Biopsy Market Size Market Share by Sample (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Liquid Biopsy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals Labs
8.2.2 Reference Labs
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Liquid Biopsy Market Size by Application (2021-2026)
8.3.2 World Liquid Biopsy Market Size by Application (2027-2032)
8.3.3 World Liquid Biopsy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 RainDanceTechnologies
9.1.1 RainDanceTechnologies Details
9.1.2 RainDanceTechnologies Major Business
9.1.3 RainDanceTechnologies Liquid Biopsy Product and Services
9.1.4 RainDanceTechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 RainDanceTechnologies Recent Developments/Updates
9.1.6 RainDanceTechnologies Competitive Strengths & Weaknesses
9.2 Biocartis
9.2.1 Biocartis Details
9.2.2 Biocartis Major Business
9.2.3 Biocartis Liquid Biopsy Product and Services
9.2.4 Biocartis Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Biocartis Recent Developments/Updates
9.2.6 Biocartis Competitive Strengths & Weaknesses
9.3 Qiagen
9.3.1 Qiagen Details
9.3.2 Qiagen Major Business
9.3.3 Qiagen Liquid Biopsy Product and Services
9.3.4 Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Qiagen Recent Developments/Updates
9.3.6 Qiagen Competitive Strengths & Weaknesses
9.4 Guardant Health
9.4.1 Guardant Health Details
9.4.2 Guardant Health Major Business
9.4.3 Guardant Health Liquid Biopsy Product and Services
9.4.4 Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Guardant Health Recent Developments/Updates
9.4.6 Guardant Health Competitive Strengths & Weaknesses
9.5 MDxHealth
9.5.1 MDxHealth Details
9.5.2 MDxHealth Major Business
9.5.3 MDxHealth Liquid Biopsy Product and Services
9.5.4 MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 MDxHealth Recent Developments/Updates
9.5.6 MDxHealth Competitive Strengths & Weaknesses
9.6 Pathway Genomics
9.6.1 Pathway Genomics Details
9.6.2 Pathway Genomics Major Business
9.6.3 Pathway Genomics Liquid Biopsy Product and Services
9.6.4 Pathway Genomics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Pathway Genomics Recent Developments/Updates
9.6.6 Pathway Genomics Competitive Strengths & Weaknesses
9.7 Biocept
9.7.1 Biocept Details
9.7.2 Biocept Major Business
9.7.3 Biocept Liquid Biopsy Product and Services
9.7.4 Biocept Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Biocept Recent Developments/Updates
9.7.6 Biocept Competitive Strengths & Weaknesses
9.8 NeoGenomics Laboraories
9.8.1 NeoGenomics Laboraories Details
9.8.2 NeoGenomics Laboraories Major Business
9.8.3 NeoGenomics Laboraories Liquid Biopsy Product and Services
9.8.4 NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 NeoGenomics Laboraories Recent Developments/Updates
9.8.6 NeoGenomics Laboraories Competitive Strengths & Weaknesses
9.9 Sysmex Inostics
9.9.1 Sysmex Inostics Details
9.9.2 Sysmex Inostics Major Business
9.9.3 Sysmex Inostics Liquid Biopsy Product and Services
9.9.4 Sysmex Inostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Sysmex Inostics Recent Developments/Updates
9.9.6 Sysmex Inostics Competitive Strengths & Weaknesses
9.10 Cynvenio
9.10.1 Cynvenio Details
9.10.2 Cynvenio Major Business
9.10.3 Cynvenio Liquid Biopsy Product and Services
9.10.4 Cynvenio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Cynvenio Recent Developments/Updates
9.10.6 Cynvenio Competitive Strengths & Weaknesses
9.11 Silicon Biosystems
9.11.1 Silicon Biosystems Details
9.11.2 Silicon Biosystems Major Business
9.11.3 Silicon Biosystems Liquid Biopsy Product and Services
9.11.4 Silicon Biosystems Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Silicon Biosystems Recent Developments/Updates
9.11.6 Silicon Biosystems Competitive Strengths & Weaknesses
9.12 Adaptive Biotechnologies
9.12.1 Adaptive Biotechnologies Details
9.12.2 Adaptive Biotechnologies Major Business
9.12.3 Adaptive Biotechnologies Liquid Biopsy Product and Services
9.12.4 Adaptive Biotechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Adaptive Biotechnologies Recent Developments/Updates
9.12.6 Adaptive Biotechnologies Competitive Strengths & Weaknesses
9.13 4D Lifetec
9.13.1 4D Lifetec Details
9.13.2 4D Lifetec Major Business
9.13.3 4D Lifetec Liquid Biopsy Product and Services
9.13.4 4D Lifetec Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 4D Lifetec Recent Developments/Updates
9.13.6 4D Lifetec Competitive Strengths & Weaknesses
9.14 Roche
9.14.1 Roche Details
9.14.2 Roche Major Business
9.14.3 Roche Liquid Biopsy Product and Services
9.14.4 Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Roche Recent Developments/Updates
9.14.6 Roche Competitive Strengths & Weaknesses
9.15 Illumina
9.15.1 Illumina Details
9.15.2 Illumina Major Business
9.15.3 Illumina Liquid Biopsy Product and Services
9.15.4 Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Illumina Recent Developments/Updates
9.15.6 Illumina Competitive Strengths & Weaknesses
9.16 Exact Sciences
9.16.1 Exact Sciences Details
9.16.2 Exact Sciences Major Business
9.16.3 Exact Sciences Liquid Biopsy Product and Services
9.16.4 Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Exact Sciences Recent Developments/Updates
9.16.6 Exact Sciences Competitive Strengths & Weaknesses
9.17 Natera
9.17.1 Natera Details
9.17.2 Natera Major Business
9.17.3 Natera Liquid Biopsy Product and Services
9.17.4 Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Natera Recent Developments/Updates
9.17.6 Natera Competitive Strengths & Weaknesses
9.18 Foundation Medicine
9.18.1 Foundation Medicine Details
9.18.2 Foundation Medicine Major Business
9.18.3 Foundation Medicine Liquid Biopsy Product and Services
9.18.4 Foundation Medicine Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Foundation Medicine Recent Developments/Updates
9.18.6 Foundation Medicine Competitive Strengths & Weaknesses
9.19 Thermo Fisher Scientific
9.19.1 Thermo Fisher Scientific Details
9.19.2 Thermo Fisher Scientific Major Business
9.19.3 Thermo Fisher Scientific Liquid Biopsy Product and Services
9.19.4 Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Thermo Fisher Scientific Recent Developments/Updates
9.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.20 Bio-Rad Laboratories
9.20.1 Bio-Rad Laboratories Details
9.20.2 Bio-Rad Laboratories Major Business
9.20.3 Bio-Rad Laboratories Liquid Biopsy Product and Services
9.20.4 Bio-Rad Laboratories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Bio-Rad Laboratories Recent Developments/Updates
9.20.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Liquid Biopsy Industry Chain
10.2 Liquid Biopsy Upstream Analysis
10.3 Liquid Biopsy Midstream Analysis
10.4 Liquid Biopsy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Liquid Biopsy Introduction
1.2 World Liquid Biopsy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Liquid Biopsy Total Market by Region (by Headquarter Location)
1.3.1 World Liquid Biopsy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Liquid Biopsy Revenue (2021-2032)
1.3.3 China Based Company Liquid Biopsy Revenue (2021-2032)
1.3.4 Europe Based Company Liquid Biopsy Revenue (2021-2032)
1.3.5 Japan Based Company Liquid Biopsy Revenue (2021-2032)
1.3.6 South Korea Based Company Liquid Biopsy Revenue (2021-2032)
1.3.7 ASEAN Based Company Liquid Biopsy Revenue (2021-2032)
1.3.8 India Based Company Liquid Biopsy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liquid Biopsy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Liquid Biopsy Consumption Value (2021-2032)
2.2 World Liquid Biopsy Consumption Value by Region
2.2.1 World Liquid Biopsy Consumption Value by Region (2021-2026)
2.2.2 World Liquid Biopsy Consumption Value Forecast by Region (2027-2032)
2.3 United States Liquid Biopsy Consumption Value (2021-2032)
2.4 China Liquid Biopsy Consumption Value (2021-2032)
2.5 Europe Liquid Biopsy Consumption Value (2021-2032)
2.6 Japan Liquid Biopsy Consumption Value (2021-2032)
2.7 South Korea Liquid Biopsy Consumption Value (2021-2032)
2.8 ASEAN Liquid Biopsy Consumption Value (2021-2032)
2.9 India Liquid Biopsy Consumption Value (2021-2032)
3 WORLD LIQUID BIOPSY COMPANIES COMPETITIVE ANALYSIS
3.1 World Liquid Biopsy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Liquid Biopsy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Liquid Biopsy in 2025
3.2.3 Global Concentration Ratios (CR8) for Liquid Biopsy in 2025
3.3 Liquid Biopsy Company Evaluation Quadrant
3.4 Liquid Biopsy Market: Overall Company Footprint Analysis
3.4.1 Liquid Biopsy Market: Region Footprint
3.4.2 Liquid Biopsy Market: Company Product Type Footprint
3.4.3 Liquid Biopsy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Liquid Biopsy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Liquid Biopsy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Liquid Biopsy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Liquid Biopsy Consumption Value Comparison
4.2.1 United States VS China: Liquid Biopsy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Liquid Biopsy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Liquid Biopsy Companies and Market Share, 2021-2026
4.3.1 United States Based Liquid Biopsy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Liquid Biopsy Revenue, (2021-2026)
4.4 China Based Companies Liquid Biopsy Revenue and Market Share, 2021-2026
4.4.1 China Based Liquid Biopsy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Liquid Biopsy Revenue, (2021-2026)
4.5 Rest of World Based Liquid Biopsy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Liquid Biopsy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Liquid Biopsy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Liquid Biopsy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Test Suite
5.2.2 Equipment
5.2.3 Service
5.3 Market Segment by Type
5.3.1 World Liquid Biopsy Market Size by Type (2021-2026)
5.3.2 World Liquid Biopsy Market Size by Type (2027-2032)
5.3.3 World Liquid Biopsy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY PLATFORM
6.1 World Liquid Biopsy Market Size Overview by Technology Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Platform
6.2.1 NGS Sequencing
6.2.2 Digital PCR
6.2.3 Real-time PCR
6.2.4 Other
6.3 Market Segment by Technology Platform
6.3.1 World Liquid Biopsy Market Size by Technology Platform (2021-2026)
6.3.2 World Liquid Biopsy Market Size by Technology Platform (2027-2032)
6.3.3 World Liquid Biopsy Market Size Market Share by Technology Platform (2027-2032)
7 MARKET ANALYSIS BY SAMPLE
7.1 World Liquid Biopsy Market Size Overview by Sample: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sample
7.2.1 Blood Sample
7.2.2 Urine Sample
7.2.3 Other
7.3 Market Segment by Sample
7.3.1 World Liquid Biopsy Market Size by Sample (2021-2026)
7.3.2 World Liquid Biopsy Market Size by Sample (2027-2032)
7.3.3 World Liquid Biopsy Market Size Market Share by Sample (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Liquid Biopsy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals Labs
8.2.2 Reference Labs
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Liquid Biopsy Market Size by Application (2021-2026)
8.3.2 World Liquid Biopsy Market Size by Application (2027-2032)
8.3.3 World Liquid Biopsy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 RainDanceTechnologies
9.1.1 RainDanceTechnologies Details
9.1.2 RainDanceTechnologies Major Business
9.1.3 RainDanceTechnologies Liquid Biopsy Product and Services
9.1.4 RainDanceTechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 RainDanceTechnologies Recent Developments/Updates
9.1.6 RainDanceTechnologies Competitive Strengths & Weaknesses
9.2 Biocartis
9.2.1 Biocartis Details
9.2.2 Biocartis Major Business
9.2.3 Biocartis Liquid Biopsy Product and Services
9.2.4 Biocartis Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Biocartis Recent Developments/Updates
9.2.6 Biocartis Competitive Strengths & Weaknesses
9.3 Qiagen
9.3.1 Qiagen Details
9.3.2 Qiagen Major Business
9.3.3 Qiagen Liquid Biopsy Product and Services
9.3.4 Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Qiagen Recent Developments/Updates
9.3.6 Qiagen Competitive Strengths & Weaknesses
9.4 Guardant Health
9.4.1 Guardant Health Details
9.4.2 Guardant Health Major Business
9.4.3 Guardant Health Liquid Biopsy Product and Services
9.4.4 Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Guardant Health Recent Developments/Updates
9.4.6 Guardant Health Competitive Strengths & Weaknesses
9.5 MDxHealth
9.5.1 MDxHealth Details
9.5.2 MDxHealth Major Business
9.5.3 MDxHealth Liquid Biopsy Product and Services
9.5.4 MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 MDxHealth Recent Developments/Updates
9.5.6 MDxHealth Competitive Strengths & Weaknesses
9.6 Pathway Genomics
9.6.1 Pathway Genomics Details
9.6.2 Pathway Genomics Major Business
9.6.3 Pathway Genomics Liquid Biopsy Product and Services
9.6.4 Pathway Genomics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Pathway Genomics Recent Developments/Updates
9.6.6 Pathway Genomics Competitive Strengths & Weaknesses
9.7 Biocept
9.7.1 Biocept Details
9.7.2 Biocept Major Business
9.7.3 Biocept Liquid Biopsy Product and Services
9.7.4 Biocept Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Biocept Recent Developments/Updates
9.7.6 Biocept Competitive Strengths & Weaknesses
9.8 NeoGenomics Laboraories
9.8.1 NeoGenomics Laboraories Details
9.8.2 NeoGenomics Laboraories Major Business
9.8.3 NeoGenomics Laboraories Liquid Biopsy Product and Services
9.8.4 NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 NeoGenomics Laboraories Recent Developments/Updates
9.8.6 NeoGenomics Laboraories Competitive Strengths & Weaknesses
9.9 Sysmex Inostics
9.9.1 Sysmex Inostics Details
9.9.2 Sysmex Inostics Major Business
9.9.3 Sysmex Inostics Liquid Biopsy Product and Services
9.9.4 Sysmex Inostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Sysmex Inostics Recent Developments/Updates
9.9.6 Sysmex Inostics Competitive Strengths & Weaknesses
9.10 Cynvenio
9.10.1 Cynvenio Details
9.10.2 Cynvenio Major Business
9.10.3 Cynvenio Liquid Biopsy Product and Services
9.10.4 Cynvenio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Cynvenio Recent Developments/Updates
9.10.6 Cynvenio Competitive Strengths & Weaknesses
9.11 Silicon Biosystems
9.11.1 Silicon Biosystems Details
9.11.2 Silicon Biosystems Major Business
9.11.3 Silicon Biosystems Liquid Biopsy Product and Services
9.11.4 Silicon Biosystems Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Silicon Biosystems Recent Developments/Updates
9.11.6 Silicon Biosystems Competitive Strengths & Weaknesses
9.12 Adaptive Biotechnologies
9.12.1 Adaptive Biotechnologies Details
9.12.2 Adaptive Biotechnologies Major Business
9.12.3 Adaptive Biotechnologies Liquid Biopsy Product and Services
9.12.4 Adaptive Biotechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Adaptive Biotechnologies Recent Developments/Updates
9.12.6 Adaptive Biotechnologies Competitive Strengths & Weaknesses
9.13 4D Lifetec
9.13.1 4D Lifetec Details
9.13.2 4D Lifetec Major Business
9.13.3 4D Lifetec Liquid Biopsy Product and Services
9.13.4 4D Lifetec Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 4D Lifetec Recent Developments/Updates
9.13.6 4D Lifetec Competitive Strengths & Weaknesses
9.14 Roche
9.14.1 Roche Details
9.14.2 Roche Major Business
9.14.3 Roche Liquid Biopsy Product and Services
9.14.4 Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Roche Recent Developments/Updates
9.14.6 Roche Competitive Strengths & Weaknesses
9.15 Illumina
9.15.1 Illumina Details
9.15.2 Illumina Major Business
9.15.3 Illumina Liquid Biopsy Product and Services
9.15.4 Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Illumina Recent Developments/Updates
9.15.6 Illumina Competitive Strengths & Weaknesses
9.16 Exact Sciences
9.16.1 Exact Sciences Details
9.16.2 Exact Sciences Major Business
9.16.3 Exact Sciences Liquid Biopsy Product and Services
9.16.4 Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Exact Sciences Recent Developments/Updates
9.16.6 Exact Sciences Competitive Strengths & Weaknesses
9.17 Natera
9.17.1 Natera Details
9.17.2 Natera Major Business
9.17.3 Natera Liquid Biopsy Product and Services
9.17.4 Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Natera Recent Developments/Updates
9.17.6 Natera Competitive Strengths & Weaknesses
9.18 Foundation Medicine
9.18.1 Foundation Medicine Details
9.18.2 Foundation Medicine Major Business
9.18.3 Foundation Medicine Liquid Biopsy Product and Services
9.18.4 Foundation Medicine Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Foundation Medicine Recent Developments/Updates
9.18.6 Foundation Medicine Competitive Strengths & Weaknesses
9.19 Thermo Fisher Scientific
9.19.1 Thermo Fisher Scientific Details
9.19.2 Thermo Fisher Scientific Major Business
9.19.3 Thermo Fisher Scientific Liquid Biopsy Product and Services
9.19.4 Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Thermo Fisher Scientific Recent Developments/Updates
9.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.20 Bio-Rad Laboratories
9.20.1 Bio-Rad Laboratories Details
9.20.2 Bio-Rad Laboratories Major Business
9.20.3 Bio-Rad Laboratories Liquid Biopsy Product and Services
9.20.4 Bio-Rad Laboratories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Bio-Rad Laboratories Recent Developments/Updates
9.20.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Liquid Biopsy Industry Chain
10.2 Liquid Biopsy Upstream Analysis
10.3 Liquid Biopsy Midstream Analysis
10.4 Liquid Biopsy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Liquid Biopsy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Liquid Biopsy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Liquid Biopsy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Liquid Biopsy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Liquid Biopsy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Liquid Biopsy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Liquid Biopsy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Liquid Biopsy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Liquid Biopsy Players in 2025
Table 12. World Liquid Biopsy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Liquid Biopsy Company Evaluation Quadrant
Table 14. Head Office of Key Liquid Biopsy Players
Table 15. Liquid Biopsy Market: Company Product Type Footprint
Table 16. Liquid Biopsy Market: Company Product Application Footprint
Table 17. Liquid Biopsy Mergers & Acquisitions Activity
Table 18. United States VS China Liquid Biopsy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Liquid Biopsy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Liquid Biopsy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Liquid Biopsy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Liquid Biopsy Revenue Market Share (2021-2026)
Table 23. China Based Liquid Biopsy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Liquid Biopsy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Liquid Biopsy Revenue Market Share (2021-2026)
Table 26. Rest of World Based Liquid Biopsy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Liquid Biopsy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Liquid Biopsy Revenue Market Share (2021-2026)
Table 29. World Liquid Biopsy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Liquid Biopsy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Liquid Biopsy Market Size by Type (2027-2032) & (USD Million)
Table 32. World Liquid Biopsy Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 33. World Liquid Biopsy Market Size Value by Technology Platform (2021-2026) & (USD Million)
Table 34. World Liquid Biopsy Market Size by Technology Platform (2027-2032) & (USD Million)
Table 35. World Liquid Biopsy Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Table 36. World Liquid Biopsy Market Size Value by Sample (2021-2026) & (USD Million)
Table 37. World Liquid Biopsy Market Size by Sample (2027-2032) & (USD Million)
Table 38. World Liquid Biopsy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Liquid Biopsy Market Size by Application (2021-2026) & (USD Million)
Table 40. World Liquid Biopsy Market Size by Application (2027-2032) & (USD Million)
Table 41. RainDanceTechnologies Basic Information, Manufacturing Base and Competitors
Table 42. RainDanceTechnologies Major Business
Table 43. RainDanceTechnologies Liquid Biopsy Product and Services
Table 44. RainDanceTechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. RainDanceTechnologies Recent Developments/Updates
Table 46. RainDanceTechnologies Competitive Strengths & Weaknesses
Table 47. Biocartis Basic Information, Manufacturing Base and Competitors
Table 48. Biocartis Major Business
Table 49. Biocartis Liquid Biopsy Product and Services
Table 50. Biocartis Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Biocartis Recent Developments/Updates
Table 52. Biocartis Competitive Strengths & Weaknesses
Table 53. Qiagen Basic Information, Manufacturing Base and Competitors
Table 54. Qiagen Major Business
Table 55. Qiagen Liquid Biopsy Product and Services
Table 56. Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Qiagen Recent Developments/Updates
Table 58. Qiagen Competitive Strengths & Weaknesses
Table 59. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 60. Guardant Health Major Business
Table 61. Guardant Health Liquid Biopsy Product and Services
Table 62. Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Guardant Health Recent Developments/Updates
Table 64. Guardant Health Competitive Strengths & Weaknesses
Table 65. MDxHealth Basic Information, Manufacturing Base and Competitors
Table 66. MDxHealth Major Business
Table 67. MDxHealth Liquid Biopsy Product and Services
Table 68. MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. MDxHealth Recent Developments/Updates
Table 70. MDxHealth Competitive Strengths & Weaknesses
Table 71. Pathway Genomics Basic Information, Manufacturing Base and Competitors
Table 72. Pathway Genomics Major Business
Table 73. Pathway Genomics Liquid Biopsy Product and Services
Table 74. Pathway Genomics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Pathway Genomics Recent Developments/Updates
Table 76. Pathway Genomics Competitive Strengths & Weaknesses
Table 77. Biocept Basic Information, Manufacturing Base and Competitors
Table 78. Biocept Major Business
Table 79. Biocept Liquid Biopsy Product and Services
Table 80. Biocept Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Biocept Recent Developments/Updates
Table 82. Biocept Competitive Strengths & Weaknesses
Table 83. NeoGenomics Laboraories Basic Information, Manufacturing Base and Competitors
Table 84. NeoGenomics Laboraories Major Business
Table 85. NeoGenomics Laboraories Liquid Biopsy Product and Services
Table 86. NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. NeoGenomics Laboraories Recent Developments/Updates
Table 88. NeoGenomics Laboraories Competitive Strengths & Weaknesses
Table 89. Sysmex Inostics Basic Information, Manufacturing Base and Competitors
Table 90. Sysmex Inostics Major Business
Table 91. Sysmex Inostics Liquid Biopsy Product and Services
Table 92. Sysmex Inostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Sysmex Inostics Recent Developments/Updates
Table 94. Sysmex Inostics Competitive Strengths & Weaknesses
Table 95. Cynvenio Basic Information, Manufacturing Base and Competitors
Table 96. Cynvenio Major Business
Table 97. Cynvenio Liquid Biopsy Product and Services
Table 98. Cynvenio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Cynvenio Recent Developments/Updates
Table 100. Cynvenio Competitive Strengths & Weaknesses
Table 101. Silicon Biosystems Basic Information, Manufacturing Base and Competitors
Table 102. Silicon Biosystems Major Business
Table 103. Silicon Biosystems Liquid Biopsy Product and Services
Table 104. Silicon Biosystems Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Silicon Biosystems Recent Developments/Updates
Table 106. Silicon Biosystems Competitive Strengths & Weaknesses
Table 107. Adaptive Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 108. Adaptive Biotechnologies Major Business
Table 109. Adaptive Biotechnologies Liquid Biopsy Product and Services
Table 110. Adaptive Biotechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Adaptive Biotechnologies Recent Developments/Updates
Table 112. Adaptive Biotechnologies Competitive Strengths & Weaknesses
Table 113. 4D Lifetec Basic Information, Manufacturing Base and Competitors
Table 114. 4D Lifetec Major Business
Table 115. 4D Lifetec Liquid Biopsy Product and Services
Table 116. 4D Lifetec Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. 4D Lifetec Recent Developments/Updates
Table 118. 4D Lifetec Competitive Strengths & Weaknesses
Table 119. Roche Basic Information, Manufacturing Base and Competitors
Table 120. Roche Major Business
Table 121. Roche Liquid Biopsy Product and Services
Table 122. Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Roche Recent Developments/Updates
Table 124. Roche Competitive Strengths & Weaknesses
Table 125. Illumina Basic Information, Manufacturing Base and Competitors
Table 126. Illumina Major Business
Table 127. Illumina Liquid Biopsy Product and Services
Table 128. Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Illumina Recent Developments/Updates
Table 130. Illumina Competitive Strengths & Weaknesses
Table 131. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 132. Exact Sciences Major Business
Table 133. Exact Sciences Liquid Biopsy Product and Services
Table 134. Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Exact Sciences Recent Developments/Updates
Table 136. Exact Sciences Competitive Strengths & Weaknesses
Table 137. Natera Basic Information, Manufacturing Base and Competitors
Table 138. Natera Major Business
Table 139. Natera Liquid Biopsy Product and Services
Table 140. Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Natera Recent Developments/Updates
Table 142. Natera Competitive Strengths & Weaknesses
Table 143. Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table 144. Foundation Medicine Major Business
Table 145. Foundation Medicine Liquid Biopsy Product and Services
Table 146. Foundation Medicine Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Foundation Medicine Recent Developments/Updates
Table 148. Foundation Medicine Competitive Strengths & Weaknesses
Table 149. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 150. Thermo Fisher Scientific Major Business
Table 151. Thermo Fisher Scientific Liquid Biopsy Product and Services
Table 152. Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Thermo Fisher Scientific Recent Developments/Updates
Table 154. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 155. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 156. Bio-Rad Laboratories Major Business
Table 157. Bio-Rad Laboratories Liquid Biopsy Product and Services
Table 158. Bio-Rad Laboratories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Bio-Rad Laboratories Recent Developments/Updates
Table 160. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 161. Global Key Players of Liquid Biopsy Upstream (Raw Materials)
Table 162. Global Liquid Biopsy Typical Customers
Table 1. World Liquid Biopsy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Liquid Biopsy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Liquid Biopsy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Liquid Biopsy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Liquid Biopsy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Liquid Biopsy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Liquid Biopsy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Liquid Biopsy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Liquid Biopsy Players in 2025
Table 12. World Liquid Biopsy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Liquid Biopsy Company Evaluation Quadrant
Table 14. Head Office of Key Liquid Biopsy Players
Table 15. Liquid Biopsy Market: Company Product Type Footprint
Table 16. Liquid Biopsy Market: Company Product Application Footprint
Table 17. Liquid Biopsy Mergers & Acquisitions Activity
Table 18. United States VS China Liquid Biopsy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Liquid Biopsy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Liquid Biopsy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Liquid Biopsy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Liquid Biopsy Revenue Market Share (2021-2026)
Table 23. China Based Liquid Biopsy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Liquid Biopsy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Liquid Biopsy Revenue Market Share (2021-2026)
Table 26. Rest of World Based Liquid Biopsy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Liquid Biopsy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Liquid Biopsy Revenue Market Share (2021-2026)
Table 29. World Liquid Biopsy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Liquid Biopsy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Liquid Biopsy Market Size by Type (2027-2032) & (USD Million)
Table 32. World Liquid Biopsy Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 33. World Liquid Biopsy Market Size Value by Technology Platform (2021-2026) & (USD Million)
Table 34. World Liquid Biopsy Market Size by Technology Platform (2027-2032) & (USD Million)
Table 35. World Liquid Biopsy Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Table 36. World Liquid Biopsy Market Size Value by Sample (2021-2026) & (USD Million)
Table 37. World Liquid Biopsy Market Size by Sample (2027-2032) & (USD Million)
Table 38. World Liquid Biopsy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Liquid Biopsy Market Size by Application (2021-2026) & (USD Million)
Table 40. World Liquid Biopsy Market Size by Application (2027-2032) & (USD Million)
Table 41. RainDanceTechnologies Basic Information, Manufacturing Base and Competitors
Table 42. RainDanceTechnologies Major Business
Table 43. RainDanceTechnologies Liquid Biopsy Product and Services
Table 44. RainDanceTechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. RainDanceTechnologies Recent Developments/Updates
Table 46. RainDanceTechnologies Competitive Strengths & Weaknesses
Table 47. Biocartis Basic Information, Manufacturing Base and Competitors
Table 48. Biocartis Major Business
Table 49. Biocartis Liquid Biopsy Product and Services
Table 50. Biocartis Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Biocartis Recent Developments/Updates
Table 52. Biocartis Competitive Strengths & Weaknesses
Table 53. Qiagen Basic Information, Manufacturing Base and Competitors
Table 54. Qiagen Major Business
Table 55. Qiagen Liquid Biopsy Product and Services
Table 56. Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Qiagen Recent Developments/Updates
Table 58. Qiagen Competitive Strengths & Weaknesses
Table 59. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 60. Guardant Health Major Business
Table 61. Guardant Health Liquid Biopsy Product and Services
Table 62. Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Guardant Health Recent Developments/Updates
Table 64. Guardant Health Competitive Strengths & Weaknesses
Table 65. MDxHealth Basic Information, Manufacturing Base and Competitors
Table 66. MDxHealth Major Business
Table 67. MDxHealth Liquid Biopsy Product and Services
Table 68. MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. MDxHealth Recent Developments/Updates
Table 70. MDxHealth Competitive Strengths & Weaknesses
Table 71. Pathway Genomics Basic Information, Manufacturing Base and Competitors
Table 72. Pathway Genomics Major Business
Table 73. Pathway Genomics Liquid Biopsy Product and Services
Table 74. Pathway Genomics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Pathway Genomics Recent Developments/Updates
Table 76. Pathway Genomics Competitive Strengths & Weaknesses
Table 77. Biocept Basic Information, Manufacturing Base and Competitors
Table 78. Biocept Major Business
Table 79. Biocept Liquid Biopsy Product and Services
Table 80. Biocept Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Biocept Recent Developments/Updates
Table 82. Biocept Competitive Strengths & Weaknesses
Table 83. NeoGenomics Laboraories Basic Information, Manufacturing Base and Competitors
Table 84. NeoGenomics Laboraories Major Business
Table 85. NeoGenomics Laboraories Liquid Biopsy Product and Services
Table 86. NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. NeoGenomics Laboraories Recent Developments/Updates
Table 88. NeoGenomics Laboraories Competitive Strengths & Weaknesses
Table 89. Sysmex Inostics Basic Information, Manufacturing Base and Competitors
Table 90. Sysmex Inostics Major Business
Table 91. Sysmex Inostics Liquid Biopsy Product and Services
Table 92. Sysmex Inostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Sysmex Inostics Recent Developments/Updates
Table 94. Sysmex Inostics Competitive Strengths & Weaknesses
Table 95. Cynvenio Basic Information, Manufacturing Base and Competitors
Table 96. Cynvenio Major Business
Table 97. Cynvenio Liquid Biopsy Product and Services
Table 98. Cynvenio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Cynvenio Recent Developments/Updates
Table 100. Cynvenio Competitive Strengths & Weaknesses
Table 101. Silicon Biosystems Basic Information, Manufacturing Base and Competitors
Table 102. Silicon Biosystems Major Business
Table 103. Silicon Biosystems Liquid Biopsy Product and Services
Table 104. Silicon Biosystems Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Silicon Biosystems Recent Developments/Updates
Table 106. Silicon Biosystems Competitive Strengths & Weaknesses
Table 107. Adaptive Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 108. Adaptive Biotechnologies Major Business
Table 109. Adaptive Biotechnologies Liquid Biopsy Product and Services
Table 110. Adaptive Biotechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Adaptive Biotechnologies Recent Developments/Updates
Table 112. Adaptive Biotechnologies Competitive Strengths & Weaknesses
Table 113. 4D Lifetec Basic Information, Manufacturing Base and Competitors
Table 114. 4D Lifetec Major Business
Table 115. 4D Lifetec Liquid Biopsy Product and Services
Table 116. 4D Lifetec Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. 4D Lifetec Recent Developments/Updates
Table 118. 4D Lifetec Competitive Strengths & Weaknesses
Table 119. Roche Basic Information, Manufacturing Base and Competitors
Table 120. Roche Major Business
Table 121. Roche Liquid Biopsy Product and Services
Table 122. Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Roche Recent Developments/Updates
Table 124. Roche Competitive Strengths & Weaknesses
Table 125. Illumina Basic Information, Manufacturing Base and Competitors
Table 126. Illumina Major Business
Table 127. Illumina Liquid Biopsy Product and Services
Table 128. Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Illumina Recent Developments/Updates
Table 130. Illumina Competitive Strengths & Weaknesses
Table 131. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 132. Exact Sciences Major Business
Table 133. Exact Sciences Liquid Biopsy Product and Services
Table 134. Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Exact Sciences Recent Developments/Updates
Table 136. Exact Sciences Competitive Strengths & Weaknesses
Table 137. Natera Basic Information, Manufacturing Base and Competitors
Table 138. Natera Major Business
Table 139. Natera Liquid Biopsy Product and Services
Table 140. Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Natera Recent Developments/Updates
Table 142. Natera Competitive Strengths & Weaknesses
Table 143. Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table 144. Foundation Medicine Major Business
Table 145. Foundation Medicine Liquid Biopsy Product and Services
Table 146. Foundation Medicine Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Foundation Medicine Recent Developments/Updates
Table 148. Foundation Medicine Competitive Strengths & Weaknesses
Table 149. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 150. Thermo Fisher Scientific Major Business
Table 151. Thermo Fisher Scientific Liquid Biopsy Product and Services
Table 152. Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Thermo Fisher Scientific Recent Developments/Updates
Table 154. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 155. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 156. Bio-Rad Laboratories Major Business
Table 157. Bio-Rad Laboratories Liquid Biopsy Product and Services
Table 158. Bio-Rad Laboratories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Bio-Rad Laboratories Recent Developments/Updates
Table 160. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 161. Global Key Players of Liquid Biopsy Upstream (Raw Materials)
Table 162. Global Liquid Biopsy Typical Customers
LIST OF FIGURES
Figure 1. Liquid Biopsy Picture
Figure 2. World Liquid Biopsy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Liquid Biopsy Total Revenue (2021-2032) & (USD Million)
Figure 4. World Liquid Biopsy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Liquid Biopsy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 13. Liquid Biopsy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 16. World Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 18. China Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 23. India Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Liquid Biopsy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liquid Biopsy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liquid Biopsy Markets in 2025
Figure 27. United States VS China: Liquid Biopsy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Liquid Biopsy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Liquid Biopsy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Liquid Biopsy Market Size Market Share by Type in 2025
Figure 31. Test Suite
Figure 32. Equipment
Figure 33. Service
Figure 34. World Liquid Biopsy Market Size Market Share by Type (2021-2032)
Figure 35. World Liquid Biopsy Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 36. World Liquid Biopsy Market Size Market Share by Technology Platform in 2025
Figure 37. NGS Sequencing
Figure 38. Digital PCR
Figure 39. Real-time PCR
Figure 40. Other
Figure 41. World Liquid Biopsy Market Size Market Share by Technology Platform (2021-2032)
Figure 42. World Liquid Biopsy Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Figure 43. World Liquid Biopsy Market Size Market Share by Sample in 2025
Figure 44. Blood Sample
Figure 45. Urine Sample
Figure 46. Other
Figure 47. World Liquid Biopsy Market Size Market Share by Sample (2021-2032)
Figure 48. World Liquid Biopsy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Liquid Biopsy Market Size Market Share by Application in 2025
Figure 50. Hospitals Labs
Figure 51. Reference Labs
Figure 52. Other
Figure 53. World Liquid Biopsy Market Size Market Share by Application (2021-2032)
Figure 54. Liquid Biopsy Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Liquid Biopsy Picture
Figure 2. World Liquid Biopsy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Liquid Biopsy Total Revenue (2021-2032) & (USD Million)
Figure 4. World Liquid Biopsy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Liquid Biopsy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Liquid Biopsy Revenue (2021-2032) & (USD Million)
Figure 13. Liquid Biopsy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 16. World Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 18. China Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 23. India Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Liquid Biopsy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liquid Biopsy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liquid Biopsy Markets in 2025
Figure 27. United States VS China: Liquid Biopsy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Liquid Biopsy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Liquid Biopsy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Liquid Biopsy Market Size Market Share by Type in 2025
Figure 31. Test Suite
Figure 32. Equipment
Figure 33. Service
Figure 34. World Liquid Biopsy Market Size Market Share by Type (2021-2032)
Figure 35. World Liquid Biopsy Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 36. World Liquid Biopsy Market Size Market Share by Technology Platform in 2025
Figure 37. NGS Sequencing
Figure 38. Digital PCR
Figure 39. Real-time PCR
Figure 40. Other
Figure 41. World Liquid Biopsy Market Size Market Share by Technology Platform (2021-2032)
Figure 42. World Liquid Biopsy Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Figure 43. World Liquid Biopsy Market Size Market Share by Sample in 2025
Figure 44. Blood Sample
Figure 45. Urine Sample
Figure 46. Other
Figure 47. World Liquid Biopsy Market Size Market Share by Sample (2021-2032)
Figure 48. World Liquid Biopsy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Liquid Biopsy Market Size Market Share by Application in 2025
Figure 50. Hospitals Labs
Figure 51. Reference Labs
Figure 52. Other
Figure 53. World Liquid Biopsy Market Size Market Share by Application (2021-2032)
Figure 54. Liquid Biopsy Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
